Literature DB >> 21054706

Paraneoplastic vasculitis and paraneoplastic vascular syndromes.

Gionata Buggiani1, Alena Krysenka, Marta Grazzini, Vladimír Vašků, Jana Hercogová, Torello Lotti.   

Abstract

Paraneoplastic syndromes are localized or diffuse pathologic manifestations that may occur in subjects affected by neoplastic diseases, even occult ones. Among the many clinical manifestations of paraneoplastic syndromes, cutaneous ones are quite common. It is estimated that skin manifestations may represent the very first diagnostic sign of a neoplastic disease in about 1% of patients. Many paraneoplastic syndromes with skin manifestations are caused by vascular alterations. In case of solid tumors, migrant thrombophlebitis and blood hypercoagulability can be seen, whereas in case of hematological neoplasms, vasculitis, and erythromelalgia can occur. Paraneoplastic vasculitis and paraneoplastic vascular syndromes are challenging issues in dermatology and general medicine. The present article will review the actual knowledge in the argument, together with providing hints for its diagnosis and management.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21054706     DOI: 10.1111/j.1529-8019.2010.01367.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  13 in total

1.  Endoscopic and radiographic features of gastrointestinal involvement in vasculitis.

Authors:  Akira Hokama; Kazuto Kishimoto; Yasushi Ihama; Chiharu Kobashigawa; Manabu Nakamoto; Tetsuo Hirata; Nagisa Kinjo; Futoshi Higa; Masao Tateyama; Fukunori Kinjo; Kunitoshi Iseki; Seiya Kato; Jiro Fujita
Journal:  World J Gastrointest Endosc       Date:  2012-03-16

2.  Paraneoplastic vasculitis in patients with metastatic renal cell carcinoma.

Authors:  Ilya Tsimafeyeu; Valentina Leonenko; Vladimir Kuznetsov; Evgenia Semenkova; Anastasia Bondarenko; Lev Demidov
Journal:  Cancer Rep (Hoboken)       Date:  2018-10-16

Review 3.  [Rheumatoid symptoms in patients with hematologic neoplasms].

Authors:  S Kleinert; P La Rosée; K Krüger
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

4.  Multiple Myeloma Mimicking a Small Vessel Vasculitis Presentation.

Authors:  Mateo Mejía-Zuluaga; Jorge Andrés Lacouture; Maria Clara Gaviria; Maria Adelaida Garcés; Ana María Mejía; Sebastián Herrera
Journal:  Case Rep Rheumatol       Date:  2020-02-12

5.  Sequential occurrence of microscopic polyangiitis and anti-glomerular basement membrane disease in a patient with small cell lung cancer: a case report.

Authors:  Yusuke Hayashi; Yuko Katayama; Minoru Sakuragi; Ayano Hayashi; Hiroko Kakita; Michihiro Uyama; Satoshi Marumo; Motonari Fukui
Journal:  J Med Case Rep       Date:  2021-02-01

6.  Vasculitis and Breast Cancer: Mind the Hint.

Authors:  Miguel Esperança-Martins; Vasco Evangelista; Salomão Fernandes; Raquel Almeida
Journal:  Case Rep Oncol       Date:  2021-03-22

7.  Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma.

Authors:  Laura Burgess; Marissa Keenan; Alan Liang Zhou; Kiefer Lypka; Delvina Hasimja Saraqini; Jeff Yao; Samuel Martin; Christopher Morash; James Watterson; Christina Canil; Robert MacRae
Journal:  Curr Oncol       Date:  2021-05-07       Impact factor: 3.677

8.  Erythromelalgia and livedo reticularis in a patient with essential thrombocythemia, acquired von Willebrand disease, and elevated anti-phospholipid antibodies.

Authors:  Thilo Gambichler; Rebecca Matip
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

9.  Erythromelalgia? A clinical study of people who experience red, hot, painful feet in the community.

Authors:  D Friberg; T Chen; G Tarr; A van Rij
Journal:  Int J Vasc Med       Date:  2013-05-15

10.  Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1/T helper type 2 imbalance: a case report.

Authors:  Satoko Oka; Kazuo Ono; Masaharu Nohgawa
Journal:  J Med Case Rep       Date:  2018-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.